SEC Form 4Coverage since Mar 19, 2026Open-market trades only
$SOPH insider trading
Over the last 12 months, SOPHiA GENETICS insiders reported 1 buy totaling $99K and 85 sales totaling $4.2M across SEC Form 4 filings. 93% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $99K 1 event
- Sold · 12m
- $4.2M 85 events
- Events · 12m
- 86 Form 4 filings, grouped
- Insiders · 12m
- 10 distinct reporters
- 10b5-1 share
- 93% of events, not dollars
Side
Price · $SOPH · 3Mvia TradingView
Top insiders · 12m
Menu PhilippeChief Medical Officer16× · $416K
Xu ZhenyuChief Scientific Officer15× · $704K
Camblong JurgiChief Executive Officer8× · $815K
Camblong JurgiExecutive Chairman8× · $1.5M
Muken RossPresident7× · $111K
All insider trades
50 of 86 events
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $7.88 | $39K | -2.3% | plan |
| Sep 14, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 4,000 | $7.88 | $32K | -0.7% | plan |
| Sep 11, 2026 | Van Well DaanChief Legal Officer · O | ▼ Sale | 6,168 | $7.63 | $47K | -1.8% | plan |
| Sep 10, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 8,500 | $7.66 | $65K | -0.2% | plan |
| Sep 8, 2026 | HIBBS KATHY LD | ▼ Sale | 6,250 | $8.13 | $51K | -6.1% | plan |
| Aug 27, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 10,000 | $8.91 | $89K | -1.8% | plan |
| Aug 25, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $8.68 | $43K | -2.3% | plan |
| Aug 25, 2026 | HIBBS KATHY LD | ▼ Sale | 6,250 | $8.68 | $54K | -5.7% | plan |
| Aug 24, 2026 | Verma AbhimanyuChief Technology Officer · O | ▼ Sale | 10,000 | $8.5 | $85K | -5.5% | plan · 2 tranches |
| Aug 21, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 20,000 | $8.17 | $163K | -3.4% | plan · 3 tranches |
| Aug 19, 2026 | Valente ManuelaChief People Officer · O | ▼ Sale | 10,000 | $7.94 | $79K | -4.5% | plan |
| Aug 13, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 4,000 | $7.52 | $30K | -0.7% | plan |
| Aug 12, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $7.52 | $38K | -2.2% | plan |
| Aug 10, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 28,500 | $7.34 | $209K | -0.8% | plan · 2 tranches |
| Aug 7, 2026 | Verma AbhimanyuChief Technology Officer · O | ▼ Sale | 5,000 | $7.6 | $38K | -2.7% | plan |
| Aug 7, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 20,000 | $7.25 | $145K | -3.3% | plan · 3 tranches |
| Aug 4, 2026 | Verma AbhimanyuChief Technology Officer · O | ▼ Sale | 5,000 | $6.95 | $35K | -2.6% | plan |
| Aug 4, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 20,000 | $6.92 | $138K | -0.6% | plan |
| Aug 4, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 10,000 | $6.92 | $69K | -1.6% | plan |
| Jul 27, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $5.66 | $28K | -2.2% | plan |
| Jul 21, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 44,381 | $6.45 | $286K | -1.3% | plan · 3 tranches |
| Jul 13, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $5.7 | $29K | -2.1% | plan |
| Jul 13, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 4,000 | $5.7 | $23K | -0.7% | plan |
| Jul 10, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 8,500 | $5.62 | $48K | -0.2% | plan |
| Jul 7, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 17,685 | $5.28 | $93K | -0.5% | plan |
| Jul 6, 2026 | CARDOZA GEORGEChief Financial Officer · O | ▼ Sale | 1,592 | $5.29 | $8K | -0.5% | plan |
| Jul 6, 2026 | Valente ManuelaChief People Officer · O | ▼ Sale | 4,241 | $5.05 | $21K | -2% | plan |
| Jul 6, 2026 | Verma AbhimanyuChief Technology Officer · O | ▼ Sale | 5,285 | $5.1 | $27K | -2.7% | plan |
| Jul 6, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 7,393 | $5.17 | $38K | -1.2% | plan |
| Jul 6, 2026 | Muken RossChief Executive Officer · O·D | ▼ Sale | 9,838 | $5.22 | $51K | -1.4% | plan |
| Jul 6, 2026 | Puylaert KevinChief Sales Officer · O | ▼ Sale | 216 | $5.03 | $1K | -0.1% | 3 tranches |
| Jul 6, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 7,393 | $5.16 | $38K | -3.1% | plan |
| Jul 6, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 22,486 | $5.26 | $118K | -0.6% | plan |
| Jun 30, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 83,679 | $6.06 | $507K | -2.3% | plan · 5 tranches |
| Jun 26, 2026 | Camblong JurgiChief Executive Officer · O·D | ▼ Sale | 51,442 | $5.8 | $298K | -1.4% | plan · 3 tranches |
| Jun 25, 2026 | Verma AbhimanyuChief Technology Officer · O | ▼ Sale | 6,944 | $5.51 | $38K | -3.4% | plan |
| Jun 25, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $5.5 | $28K | -2% | plan |
| Jun 22, 2026 | CARDOZA GEORGEChief Financial Officer · O | ▼ Sale | 774 | $5.38 | $4K | -0.2% | plan |
| Jun 22, 2026 | Muken RossPresident · O | ▼ Sale | 422 | $5.38 | $2K | -0.1% | plan |
| Jun 15, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 4,000 | $5.01 | $20K | -0.6% | plan |
| Jun 12, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $4.95 | $25K | -2% | plan |
| Jun 10, 2026 | Camblong JurgiChief Executive Officer · O·D | ▼ Sale | 8,500 | $5.24 | $45K | -0.2% | plan |
| Jun 5, 2026 | CARDOZA GEORGEChief Financial Officer · O | ▲ Buy | 20,000 | $4.95 | $99K | +6.9% | — |
| May 26, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $4.95 | $25K | -2% | plan · late |
| Apr 27, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $4.82 | $24K | -1.9% | plan |
| Apr 20, 2026 | Valente ManuelaChief People Officer · O | ▼ Sale | 380 | $5.2 | $2K | -0.2% | plan |
| Apr 20, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 608 | $5.21 | $3K | -0.1% | plan |
| Apr 20, 2026 | Van Well DaanChief Legal Officer · O | ▼ Sale | 684 | $5.2 | $4K | -0.2% | plan |
| Apr 20, 2026 | Camblong JurgiChief Executive Officer · O·D | ▼ Sale | 4,486 | $5.2 | $23K | -0.1% | plan |
| Apr 20, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 608 | $5.2 | $3K | -0.2% | plan |
Every $SOPH filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? SOPHiA GENETICS filings can reach your inbox instead.
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SOPH feed.